Moreover, treating chronic pain patients with TRPV1 antagonists may produce untoward side effects, such as hyperthermia, increased susceptibility to cardiovascular diseases, etc. [60,61,89]. The gene discussed is TRPV1; the disease is cardiovascular disorder.